Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Kanathip	Singsai

Kanathip Singsai

University of Phayao, Phayao, Thailand

Title: The effect of Streblus asper leaf extract on scopolamine induced memory impairment in zebrafish

Biography

Biography: Kanathip Singsai

Abstract

Streblus asper (SA) belonging Moraceae family is well-known as a folk medicinal plant in Asian countries. This study aimed to investigate the effect of SA leaf extract on preventing memory impairment in zebrafish that is induced by scopolamine. This research using male zebrafish, Danio rerio. The zebrafish were divided into 6 groups including, control group, scopolamine (SCO) group, scopolamine plus rivastigmine 1.5 mg/kg (RV+SCO) group, scopolamine plus SA leaf extract at dose 200, 400 and 800 mg/kg (SA200+SCO, S400+SCO, and SA800+SCO) group, respectively. Spatial memory was evaluated by Colour biased appetite conditioning T-maze test while fear memory was measured by Inhibitory avoidance test. In spatial memory test, the results showed that the RV+SCO group had the best time spent in the green arm and the red arm ratio in the T-maze, followed by SA800+SCO, SA400+SCO, SA200+SCO, control, and SCO group, respectively. However, it had no statistically significant. In fear memory test, the result showed that zebrafishes received SA at dose 200, 400, and 800 mg/kg had significantly increased latency time as 21.75 ± 4.59, 23.75 ± 13.01, and 18.20 ± 18.84 min, respectively when compared to the SCO group (9.80 ± 10.45 min). These results suggested that SA leaf extract might prevent memory impairment in zebrafish especially in fear memory. These findings can be a part of the information for further research to develop SA extract to be the health products to prevent memory impairment or Alzheimer’s disease in the future.